The diagnosis of NAFLD, NASH and the more progressed stages of liver diseases including cirrhosis profoundly depend on the histological results of liver biopsies in the clinical examinations, while in routinely performed medical examinations, the definition of NAFLD is usually based on the measurements of the so called liver enzymes, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and on a synopsis of NAFLD-related risk factors like body mass index, sex, age, blood platelet count and others1,3,4,8. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.